John Cullity
Presidente presso HaemaLogiX Pty Ltd.
Patrimonio netto: 8 M $ in data 31/05/2024
Posizioni attive di John Cullity
Società | Posizione | Inizio | Fine |
---|---|---|---|
Biosynergy Partners LLC | Corporate Officer/Principal | 01/09/2013 | - |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Direttore/Membro del Consiglio | 01/09/2016 | - |
HaemaLogiX Pty Ltd.
HaemaLogiX Pty Ltd. BiotechnologyHealth Technology HaemaLogiX Pty Ltd. is a biotech company located in Sydney, Australia. The Australian company has a wide range and depth of experience in antibody research, nonclinical & clinical development, manufacturing, and commercialization. The scientific advisory board members are internationally recognized experts in monoclonal antibody therapies and hematology. The company's current research and clinical trial partners are leaders in multiple myeloma and AL amyloidosis therapy. Founded in 2014, the company is researching immune-based treatments such as monoclonal antibodies, CAR T cell therapies, and bispecific antibodies to target unique antigens on malignant cells and improve the quality of life of patients suffering from blood cancers like multiple myeloma and other life-threatening diseases like AL amyloidosis. Bryce D. Carmine has been the CEO of the company since 2015. | Presidente | - | - |
Direttore/Membro del Consiglio | 01/01/2015 | - | |
The Royal College of Physicians | Corporate Officer/Principal | - | - |
Storia della carriera di John Cullity
Precedenti posizioni note di John Cullity
Società | Posizione | Inizio | Fine |
---|---|---|---|
RACE ONCOLOGY LIMITED | Direttore/Membro del Consiglio | 20/04/2023 | 22/08/2023 |
Presidente | 06/03/2020 | 20/04/2023 | |
Ceramedix Holdings LLC | Direttore/Membro del Consiglio | 01/07/2015 | 01/03/2020 |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2010 | 01/01/2017 |
Sanofi-Aventis Healthcare Pty Ltd. | Corporate Officer/Principal | - | - |
Merk Sharp & Dohme (Holdings) Pty Ltd.
Merk Sharp & Dohme (Holdings) Pty Ltd. Pharmaceuticals: MajorHealth Technology Merk Sharp & Dohme (Holdings) Pty Ltd. develops, manufactures and markets drug therapies. The company was founded in 1958 and is headquartered in Macquarie Park, Australia. | Corporate Officer/Principal | - | - |
░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di John Cullity
London School of Economics & Political Science | Graduate Degree |
The University of Western Australia | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Australia | 6 |
Regno Unito | 3 |
Posizioni
Corporate Officer/Principal | 6 |
Director/Board Member | 4 |
Chairman | 2 |
Settori
Health Technology | 6 |
Consumer Services | 5 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
RACE ONCOLOGY LIMITED | Health Technology |
Aziende private | 8 |
---|---|
Sanofi-Synthelabo, Inc. | Health Technology |
Merk Sharp & Dohme (Holdings) Pty Ltd.
Merk Sharp & Dohme (Holdings) Pty Ltd. Pharmaceuticals: MajorHealth Technology Merk Sharp & Dohme (Holdings) Pty Ltd. develops, manufactures and markets drug therapies. The company was founded in 1958 and is headquartered in Macquarie Park, Australia. | Health Technology |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Finance |
Sanofi-Aventis Healthcare Pty Ltd. | |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Health Technology |
HaemaLogiX Pty Ltd.
HaemaLogiX Pty Ltd. BiotechnologyHealth Technology HaemaLogiX Pty Ltd. is a biotech company located in Sydney, Australia. The Australian company has a wide range and depth of experience in antibody research, nonclinical & clinical development, manufacturing, and commercialization. The scientific advisory board members are internationally recognized experts in monoclonal antibody therapies and hematology. The company's current research and clinical trial partners are leaders in multiple myeloma and AL amyloidosis therapy. Founded in 2014, the company is researching immune-based treatments such as monoclonal antibodies, CAR T cell therapies, and bispecific antibodies to target unique antigens on malignant cells and improve the quality of life of patients suffering from blood cancers like multiple myeloma and other life-threatening diseases like AL amyloidosis. Bryce D. Carmine has been the CEO of the company since 2015. | Health Technology |
Biosynergy Partners LLC | |
Ceramedix Holdings LLC |
- Borsa valori
- Insiders
- John Cullity
- Esperienza